These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11983517)

  • 1. 4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-L-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitors.
    Wallén EA; Christiaans JA; Saario SM; Forsberg MM; Venäläinen JI; Paso HM; Männistö PT; Gynther J
    Bioorg Med Chem; 2002 Jul; 10(7):2199-206. PubMed ID: 11983517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2(S)-(Cycloalk-1-enecarbonyl)-1-(4-phenyl-butanoyl)pyrrolidines and 2(S)-(aroyl)-1-(4-phenylbutanoyl)pyrrolidines as prolyl oligopeptidase inhibitors.
    Jarho EM; Venäläinen JI; Poutiainen S; Leskinen H; Vepsäläinen J; Christiaans JA; Forsberg MM; Männistö PT; Wallén EA
    Bioorg Med Chem; 2007 Mar; 15(5):2024-31. PubMed ID: 17215128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides.
    Wallén EA; Christiaans JA; Jarho EM; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J
    J Med Chem; 2003 Oct; 46(21):4543-51. PubMed ID: 14521416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors.
    Wallén EA; Christiaans JA; Saarinen TJ; Jarho EM; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J
    Bioorg Med Chem; 2003 Aug; 11(17):3611-9. PubMed ID: 12901906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.
    Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J
    J Med Chem; 2002 Sep; 45(20):4581-4. PubMed ID: 12238937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors.
    Venäläinen JI; Garcia-Horsman JA; Forsberg MM; Jalkanen A; Wallén EA; Jarho EM; Christiaans JA; Gynther J; Männistö PT
    Biochem Pharmacol; 2006 Feb; 71(5):683-92. PubMed ID: 16405869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
    Jarho EM; Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J; Poso A
    J Med Chem; 2005 Jul; 48(15):4772-82. PubMed ID: 16033257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819.
    Venäläinen JI; Juvonen RO; Forsberg MM; Garcia-Horsman A; Poso A; Wallen EA; Gynther J; Männistö PT
    Biochem Pharmacol; 2002 Aug; 64(3):463-71. PubMed ID: 12147298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo.
    Kallinen A; Todorov B; Kallionpää R; Bäck S; Sarparanta M; Raki M; García-Horsman JA; Bergström KA; Wallén EA; Männistö PT; Airaksinen AJ
    Eur J Med Chem; 2014 May; 79():436-45. PubMed ID: 24763264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).
    Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors.
    Kilpeläinen TP; Tyni JK; Lahtela-Kakkonen MK; Eteläinen TS; Myöhänen TT; Wallén EAA
    ACS Med Chem Lett; 2019 Dec; 10(12):1635-1640. PubMed ID: 31857839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of peptide-based prolyl oligopeptidase inhibitors--introduction of N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine as a lead in inhibitor design.
    Goossens F; Vanhoof G; De Meester I; Augustyns K; Borloo M; Tourwe D; Haemers A; Scharpé S
    Eur J Biochem; 1997 Nov; 250(1):177-83. PubMed ID: 9432007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New potent prolyl endopeptidase inhibitors: synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues.
    Tanaka Y; Niwa S; Nishioka H; Yamanaka T; Torizuka M; Yoshinaga K; Kobayashi N; Ikeda Y; Arai H
    J Med Chem; 1994 Jun; 37(13):2071-8. PubMed ID: 8027988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prolyl oligopeptidase by Fmoc-aminoacylpyrrolidine-2-nitriles.
    Li J; Wilk E; Wilk S
    J Neurochem; 1996 May; 66(5):2105-12. PubMed ID: 8780042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules.
    Kánai K; Arányi P; Böcskei Z; Ferenczy G; Harmat V; Simon K; Bátori S; Náray-Szabo G; Hermecz I
    J Med Chem; 2008 Dec; 51(23):7514-22. PubMed ID: 19006380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.
    Venäläinen JI; Juvonen RO; Garcia-Horsman JA; Wallén EA; Christiaans JA; Jarho EM; Gynther J; Männistö PT
    Biochem J; 2004 Sep; 382(Pt 3):1003-8. PubMed ID: 15217351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi.
    Joyeau R; Maoulida C; Guillet C; Frappier F; Teixeira AR; Schrével J; Santana J; Grellier P
    Eur J Med Chem; 2000 Feb; 35(2):257-66. PubMed ID: 10758287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.
    Portevin B; Benoist A; Rémond G; Hervé Y; Vincent M; Lepagnol J; De Nanteuil G
    J Med Chem; 1996 Jun; 39(12):2379-91. PubMed ID: 8691432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and inhibitory activity of acyl-peptidyl-pyrrolidine derivatives toward post-proline cleaving enzyme; a study of subsite specificity.
    Saito M; Hashimoto M; Kawaguchi N; Shibata H; Fukami H; Tanaka T; Higuchi N
    J Enzyme Inhib; 1991; 5(1):51-75. PubMed ID: 1669438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.